Loading
A phase 2 trial of fulzerasib and cetuximab in lung cancer, run by Guangdong Association of Clinical Trials, now recruiting.
IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation is a phase 2, interventional study registered as NCT07198841 by Guangdong Association of Clinical Trials, with a registry enrolment figure of 48 participants, started 2025-11-03 and due to reach its primary completion in 2027-09. Interventions recorded: IBI351 combined with cetuximab β. Conditions listed: Lung Cancer (Non-Small Cell). Primary outcome: Objective Response Rate. Lung eligibility wording from the registry: "Histologically or cytologically confirmed unresectable locally advanced (Stage IIIB/IIIC), metastatic, or recurrent (Stage IV) non-small cell lung cancer (NSCLC), per the International Association for the Study of Lung Cancer (IASLC) and American Joint Committee on Cancer (AJCC) 8th edition TNM stag". Sites: China. No results are recorded here; the registry entry is the source.
Shares Fulzerasib, Innovent Biologics, KRAS G12C-mutant non-small-cell lung cancer, KRAS & RAS inhibitors and the tag lung-deep-dive.
Shares KRAS G12C-mutant non-small-cell lung cancer, KRAS & RAS inhibitors, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares KRAS G12C-mutant non-small-cell lung cancer, KRAS & RAS inhibitors, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Innovent Biologics, Lung cancer trials open today (registry snapshot), Monoclonal antibodies and the tag lung-deep-dive.
Shares KRAS G12C-mutant non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares KRAS G12C-mutant non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Innovent Biologics, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Innovent Biologics, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.